Recent evidence shows that hypoxia-inducible factor 2 alpha (HIF-2a) may have critical roles in the growth and progression of neuroblastoma (NB) under non-hypoxic conditions. However, the underlying mechanisms and clinical potentials of normoxic HIF-2a expression in NB still remain largely unknown. In this study, HIF-2a immunostaining was identified in 26/42 NB tissues, which was correlated with clinicopathological features. In subtotal 20 NB cases, microRNA-145 (miR-145) was downregulated and inversely correlated with HIF-2a expression. Bioinformatics analysis revealed a putative miR-145 binding site in the 3 0 -untranslated region (3 0 -UTR) of HIF-2a messenger RNA (mRNA). Overexpression or knockdown of miR-145 responsively altered both the mRNA and protein levels of HIF-2a and its downstream genes, cyclin D1, matrix metalloproteinase 14 and vascular endothelial growth factor, in normoxically cultured NB cell lines SH-SY5Y and SK-N-SH. In a luciferase reporter system, miR-145 downregulated the luciferase activity of HIF-2a 3 0 -UTR, and these effects were abolished by a mutation in the putative miR-145-binding site. Overexpression of miR-145 suppressed the growth, invasion, metastasis and angiogenesis of SH-SY5Y and SK-N-SH cells in vitro and in vivo, while restoration of HIF-2a expression rescued the tumor cells from miR-145-mediated defects in these biological features. Furthermore, anti-miR-145 inhibitor rescued the HIF-2a knockdown-mediated repression on the growth, migration, invasion and angiogenesis of NB cells. These data indicate that miR-145 suppresses HIF-2a expression via the binding site in the 3 0 -UTR under normoxic conditions, thus inhibiting the aggressiveness and angiogenesis of NB.
INTRODUCTION
Neuroblastoma (NB), a malignant embryonal tumor of sympathetic nervous system, is the most common solid extracranial malignancy of childhood and accounts for 15% of all childhood cancer deaths. 1 The biological behavior of NB is extensively heterogeneous, ranging from spontaneous regression to rapid progression despite multimodal aggressive therapy. 1 Better elucidating the mechanisms for the aggressive progression of NB is needed for improving the therapeutic efficiencies. 1 Recent evidence shows that hypoxia-inducible factor 2 alpha (HIF-2a), the oxygen-sensitive submit of transcription factor HIF-2, is aberrantly expressed in non-hypoxic tumor areas of NB tissues 2 and may have critical roles in tumor aggressiveness and angiogenesis under normoxic conditions. 2 However, the underlying mechanisms and clinical potentials of HIF-2a-mediated pseudohypoxic phenotype in NB still remain largely unknown.
Emerging evidence shows that microRNAs (miRNAs), a new class of small noncoding RNAs, participate in regulating gene expression at the post-transcriptional level by targeting the 3 0 untranslated region (3 0 -UTR) of messenger RNAs (mRNAs). 3 Dysregulation of certain miRNAs has been implicated in the pathogenesis of NB. 3 For example, miR-34a and miR-184 are significantly underexpressed in primary NB tissues. 4, 5 miR-34a exerts the tumor-suppressive function by targeting MYCN, 4 while ectopic upregulation of miR-184 induces apoptosis of NB cells through targeting v-akt murine thymoma viral oncogene homolog 2. 5 Some members of miR-17-5p-92 polycistronic cluster, such as miR-17-5p, -18a, -19a, -20a and -92, are upregulated in NB and act in an oncogenic manner. 6 miR-17-5p directly targets the tumor-suppressor gene p21 to promote cell proliferation and tumorigenesis 6 and also possesses the anti-apoptotic effects via targeting the pro-apoptotic Bcl-2 interacting mediator of cell death. 6 However, studies on the roles of miRNAs in the pathogenesis of NB are still in its infancy, and it is currently urgent to further investigate the expression and function of miRNAs in the tumor biology of NB.
MicroRNA-145 (miR-145) is a kind of miRNA that is enriched in germline and mesoderm-derived tissues, such as uterus, ovary, testis, spleen, heart and prostate. 7 Downregulation of miR-145 was first noted in the pre-adenomatous polyp, suggesting its possible role in early stage of colorectal cancer. 8 Since then, emerging evidence shows that miR-145 is downregulated and acts as a tumor suppressor in various human malignancies, including prostate cancer, 9 breast cancer, 10 and esophageal squamous cell carcinoma. 11 Recent studies indicate that miR-145 is downregulated in primary central nervous system lymphoma 12 and is a critical regulator of glioblastoma invasion, 13 implying the potential roles of miR-145 in nervous system tumors. However, the exact function and downstream targets of miR-145 in NB still remain elusive. In the current study, based on computational algorithms, we predicted the miR-145 as a regulator of HIF-2a expression. We demonstrate, for the first time, that miR-145 is downregulated in NB tissues and cell lines and directly targets the 3 0 -UTR of HIF-2a under normoxic conditions, thus suppressing the growth, invasion, metastasis and angiogenesis of NB cells in vitro and in vivo.
RESULTS
Normoxic HIF-2a expression was inversely correlated with endogenous miR-145 levels in NB tissues and cell lines To investigate the expression of HIF-2a in NB, paraffin-embedded sections from 42 well-established primary cases were collected. 14 Immunohistochemical staining revealed that HIF-2a was expressed in the nuclei or cytoplasm of tumor cells in CD31-positive well-vascularized and apparently non-hypoxic lesions of NB ( Figure 1a ). HIF-2a was detected in 26/42 cases (61.9%), and the staining was weak in 8, moderate in 9 and intense in 9 (Supplementary Table S1 ). The HIF-2a immunoreactivity was significantly higher in NB cases with age 41 year (P ¼ 0.004), poorer differentiation (P ¼ 0.006), higher mitosis karyorrhexis index (P ¼ 0.007), advanced international neuroblastoma staging system stages (P ¼ 0.016) (Supplementary Table S1 ) and higher CD31 expression (Supplementary Table S2 ). The immunostaining of HIF-2a downstream target genes cyclin D1, 15 matrix metalloproteinase 14 (MMP-14) 16 and vascular endothelial growth factor (VEGF) 2 was associated with HIF-2a immunoreactivity in NB cases (Figure 1a and Supplementary  Table S2 ). In addition, western blot and real-time quantitative reverse transcription-PCR (RT-PCR) were applied to measure the expression levels of HIF-2a and mature miR-145 in subtotal 20 NB specimens, normal dorsal ganglia and cultured IMR32, SK-N-AS, SH-SY5Y and SK-N-SH cell lines. As shown in Figures 1b and c, higher levels of HIF-2a and its downstream genes cyclin D1, MMP-14 and VEGF were observed in NB tissues and cell lines than those in normal dorsal ganglia. By contrast, mature miR-145 was downregulated in NB tissues and cell lines compared with normal dorsal ganglia (Figure 1d and Supplementary Table S3 ). There was an inverse correlation between miR-145 levels and HIF-2a expression in NB tissues (Figures 1e and f) . Moreover, hypoxic (1% O 2 or 5% O 2 ) exposure did not influence the miR-145 levels in SH-SY5Y and SK-N-SH cells (Supplementary Figure S1) . These results indicated normoxic HIF-2a expression in primary NB tissues and cell lines was inversely correlated with endogenous miR-145 levels.
miR-145 downregulated HIF-2a expression through posttranscriptional repression To investigate the hypothesis that miR-145 may influence the HIF2a expression in NB, computational prediction was performed by miRNA databases. In the HIF-2a 3 0 -UTR, there was one potential binding site of miR-145 with high complementarity (Figure 2a 
DISCUSSION
In humans, HIF-2a is commonly increased in a variety of human tumors and correlates with tumor angiogenesis and patient mortality. In this study, HIF-2a expression was detected in wellvascularized regions of NB specimens and normoxically cultured NB cell lines, which is consistent with previous findings that HIF-2a in NB, as opposed to HIF-1a, is not degraded in presumably welloxygenized areas. 2 Furthermore, we noted that high HIF-2a protein levels were correlated with advanced clinical stage and predicted poor prognosis in a clinical NB material. Recent studies indicate that a fraction of cells staining intensely for HIF-2a are the NB tumor initiating or stem cells under normoxic conditions, which could explain why the presence of such cells so strongly associates with unfavorable disease. 27 Knock down of HIF-2a reduced the growth of NB tumors in athymic mice, demonstrating an important role of HIF-2a in determining an aggressive NB behavior.
2 Thus, the pseudo-hypoxic phenotypes of HIF-2a are attractive therapeutic targets for NB, and the underlying mechanisms warrant further investigation.
HIF-2a can be induced by non-hypoxic mechanisms involving growth factor-induced or oncogenic activation of translational and transcriptional pathways. Previous studies have shown the roles of miRNAs in the regulation of HIF-1a. For example, miR-519c directly binds to HIF-1a 3 0 -UTR and acts as a hypoxia-independent regulator of HIF-1a to reduce tumor angiogenesis. 28 Inhibition of However, rare evidence shows the roles of miRNAs in the transcriptional or translational regulation of HIF-2a. In this study, we demonstrated that miR-145 was downregulated and inversely correlated with HIF-2a expression in NB tissues and cell lines. Our experimental evidence further demonstrated that HIF-2a was a target of miR-145 under normoxic conditions. First, the ability of miR-145 to regulate HIF-2a expression was likely direct due to its high complementarity to the 3 0 -UTR of HIF-2a mRNA. Second, the activities of HIF-2a 3 0 -UTR luciferase reporter were responsive to HIF-2a has a pivotal role in promoting tumor aggressiveness and angiogenesis. Specific activation of HIF-2a, but not HIF-1a, is sufficient to promote tumor growth in VHL-deficient renal cell carcinoma. 17 Teratomas derived from HIF-2a knock-in embryonic stem cells are larger and exhibit increased vascularity and VEGF expression. 18 However, it has been shown that overexpression of HIF-2a in rat glioma tumor reduces tumor growth. 30 Thus, the importance of HIF-2a in tumor growth probably depends on the tumor type. HIF-2a activates the expression of cyclin D1, a well-characterized protein that regulates cell cycle G1/S transition to promote cell growth, in cultured renal cell carcinoma cells. 15 MMP-14, a membrane-bound MMP that degrades several extracellular matrix components, not only orchestrates many key aspects of tumor invasion and metastasis 31 but also contributes to angiogenic process and vascular regression. 32 Previous studies have shown the direct regulation of MMP-14 by HIF-2a in renal cell carcinoma. 16 In this study, we found that cyclin D1, MMP-14 In addition, we demonstrated that overexpression of miR-145 attenuated the growth, invasion, metastasis and angiogenesis of NB cells, which was similar to that of HIF-2a knockdown, suggesting the potential application of miR-145 as a target for the therapeutics of NB. It has been established that the functions and target genes of miRNA are tumor-type specific. 33 Through functional studies, miR-145 has shown the dual tumor suppressive and oncogenic phenotypes in different cell lines and animal models. As a tumor suppressor, miR-145 inhibits tumor cell growth through targeting insulin receptor substrate 1 (IRS1) and Friend leukemia virus integration 1 (Fli1) in colon cancer, 19, 20 rhotekin (RTKN) and c-Myc in breast cancer 10, 21 and Fascin homolog 1 (FSCN1) in esophageal carcinoma.
11 miR-145 impacts migration, invasion and metastasis by targeting junctional adhesion molecule A (JAM-A) in breast cancer, 23 SWAP switching B-cell complex 70 kDa subunit (SWAP70) in prostate cancer, 9 N-cadherin in gastric cancer 24 and neural precursor cell expressed, developmentally downregulated 9 (NEDD9) in glioblastoma. 25 In addition, miR-145 serves as a tumor suppressor that inhibits tumor growth and angiogenesis by targeting p70S6K1 in colon and ovary cancer 26 and N-RAS and VEGF in breast cancer. 22 However, miR-145 promotes anchorage-independent growth and exerts an oncogenic effect in metastatic colorectal cancer SW620 cells by downregulating E-cadherin expression. 34 In this study, our results indicated that miR-145 did not directly target or affect the expression of these reported target genes in NB cells, and restoration of HIF-2a expression within the physiological range in miR-145 overexpressing NB cells rescued their defects in aggressiveness and angiogenesis, suggesting that downregulation of HIF-2a, at least in part, contributed to the tumorsuppressive roles of miR-145 in NB. Recent evidence shows that the sequence complementarity and binding thermodynamics have an essential role in the interaction of miRNA with its targets, 35 and the sequence variations such as single-nucleotide polymorphisms in the seed region or in a target site can alter the miRNA-mRNA interaction and affect the expression of miRNA targets in diverse tumors. 36 Thus, we hypothesize that the tumortype specific function of miR-145 may be due to these sequence variations, which warrants our further investigation.
In summary, for the first time, we have demonstrated that miR-145 expression is downregulated in human NB, and ectopic expression of miR-145 can efficiently inhibit the growth, invasion, metastasis, and angiogenesis of NB cells in vitro and in vivo through direct targeting the 3 0 -UTR of HIF-2a. This study extends our knowledge about the regulation of HIF-2a at the post-transcriptional level by miRNA and suggests that miR-145 may be of potential values as a novel therapeutic target for NB.
MATERIALS AND METHODS

Patient tissue samples
Approval to conduct this study was obtained from the Institutional Review Board of Tongji Medical College. Paraffin-embedded specimens from 42 well-established primary NB cases were obtained from the Department of Pediatric Surgery, Union Hospital of Tongji Medical College.
14 The pathological diagnosis of NB was confirmed by at least two pathologists. Based on Shimada classification system, including the mitosis karyorrhexis index, degree of neuroblastic differentiation and stromal maturation, and patient's age, 19 patients were classified as favorable histology and 23 as unfavorable histology. According to international neuroblastoma staging system, 7 patients were classified as stage 1, 7 as stage 2, 9 as stage 3, 11 as stage 4 and 8 as stage 4S. In subtotal 20 NB patients, fresh tumor specimens were collected at surgery and stored at À 80 1C until use. Protein and RNAs of normal human dorsal ganglia were obtained from Clontech (Mountain View, CA, USA).
Immunohistochemistry
Immunohistochemical staining was performed as previously described, 
Quantification of miR-145 expression
The levels of mature miR-145 in primary tissues and cell lines were determined using Bulge-Loop miRNAs qPCR Primer Set (RiboBio Co. Ltd, Guangzhou, China). After cDNA was synthesized with a miRNA-specific stem-loop primer, the quantitative PCR was performed with the specific primers (Supplementary Table S4 ). The miR-145 levels were normalized as to those of U6 snRNA.
miRNA target prediction miRNA targets were predicted using the algorithms, including miRanda Human miRNA Targets, miRDB, RNA22 and Targetscan. To identify the genes commonly predicted by these four different algorithms, results of predicted targets were intersected using miRWalk. Table S5 ) and inserted between the restrictive sites Xho I and Not I of firefly/Renilla luciferase reporter vector pmiR-RB-REPORT (RiboBio Co. Ltd). Tumor cells were plated at 1 Â 10 5 cells/ well on 24-well plates and transfected with luciferase reporter vectors (30 ng). Twenty-four hours post-transfection, firefly and Renilla luciferase activities were consecutively measured, according to the dual-luciferase assay manual (Promega). The renilla luciferase signal was normalized to the firefly luciferase signal for each individual analysis.
HIF-2a overexpression and knock down
Human HIF-2a cDNA (2613 bp) was amplified from NB tissue (Supplementary Table S5 ), subcloned into the Hind III and Xho I restrictive sites of pcDNA3.1/Zeo( þ ) (Invitrogen). To restore the miR-145-induced downregulation of HIF-2a, stable cell lines were transfected with the recombinant vector pcDNA3.1-HIF2a. The 21-nucleotide siRNA targeting the encoding region of HIF-2a 39 was chemically synthesized (RiboBio Co. Ltd) and transfected with Genesilencer Transfection Reagent (Genlantis, San Diego, CA, USA). The si-Scb was applied as controls (Supplementary  Table S5 ).
Soft agar assay
Tumor cells at 5 Â 10 3 were mixed with 0.05% Nobel agar (Fisher Scientific, Pittsburgh, PA, USA) in growth medium and plated onto 6-well plates containing a solidified bottom layer (0.1% Noble agar in growth medium). After the incubation of cells for 21 days, the number of cell colonies was counted under the microscope, and the cells were fixed with 100% methanol and stained with 0.5% crystal violet dye.
Cell migration and invasion assay
The migration assay was performed with Transwell inserts that have 6.5-mm polycarbonate membranes with pores 8.0-mm in size (Corning, New York, NY, USA). Matrigel invasion assay was performed using membranes coated with Matrigel matrix (BD Science, Sparks, MD, USA). Homogeneous single-cell suspensions (1 Â 10 5 cells/well) were added to the upper chambers and allowed to invade for 24 h at 37 1C in a CO 2 incubator. Migrated or invaded cells were stained with 0.1% crystal violet for 10 min at room temperature and examined by light microscopy. Quantification of migrated or invaded cells was performed according to the published criteria. 37 Tube formation assay Fifty microliters of growth factor-reduced matrigel were polymerized on 96-well plates. HUVECs were serum starved in RPMI1640 medium for 24 h, suspended in RPMI1640 medium preconditioned with tumor cells, added to the matrigel-coated wells at the density of 5 Â 10 4 cells/well and incubated at 37 1C for 18 h. Quantification of anti-angiogenic activity was calculated by measuring the length of tube walls formed between discrete endothelial cells in each well relative to the control. 37 In vivo growth, metastasis and angiogenesis assay
All animal experiments were approved by the Animal Care Committee of Tongji Medical College (approval number: Y20080290). For the in vivo tumor growth studies, 2-month-old male nude mice (n ¼ 5 per group) were injected subcutaneously in the upper back with 1 Â 10 6 tumor cells stably transfected with empty vector or miR-145 precursor. One month later, mice were killed and examined for tumor weight, gene expression and angiogenesis. The experimental metastasis (0.4 Â 10 6 tumor cells per mouse, n ¼ 6 per group) studies were performed with 2-month-old male nude mice as previously described. 40 
Statistical analysis
Unless otherwise stated, all data were shown as mean ± s.e.m. The SPSS 12.0 statistical software (SPSS Inc., Chicago, IL, usa) was applied for statistical analysis. The w 2 analysis and Fisher exact probability analysis were applied for comparison among the expression of HIF-2a, cyclin D1, MMP-14, VEGF, CD31 and individual clinicopathological features. Pearson's coefficient correlation was applied for analyzing the relationship between miR-145 and HIF-2a expression. Difference of tumor cells was determined by t test or analysis of variance.
